Sindromi paraneoplastiche del sistema nervoso centrale

Clinica Terapeutica

Volumn 151, Issue 4, 2000, Pages 279-282

  Silvestris, Nicola ^a   Lucarelli, A ^a   Scaringella, P ^a   Di Ciaula, A ^a   Ambrosini, S ^a   Fata, L ^a  

^a Ospedale Vittorio Emanuele II   (Italy)

Author keywords

Central nervous system; Malignancy; Neuroblastoma; Paraneoplastic syndrome

Indexed keywords

DIFFERENTIAL DIAGNOSIS; HUMAN; PARANEOPLASTIC NEUROPATHY; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;

EID: 0039381413     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Dalman JO, Posner JB: Paraneoplastic syndromes affecting the nervous system. Semin Oncol 24: 318-328, 1997
2. Berardi T, Silvestris N, Moramarco S et al.: Le sindromi paraneoplastiche di prevalente interesse chirurgico. Folia Oncologica 19: 33-145, 1996
3. Nathanson L, Hall TC: Paraneoplastic syndromes. Semin Oncol 24: 265-372, 1997
4. Odell W: Metabolic syndromes of cancer. Semin Oncol 24: 299-317, 1997
5. Posner JB: Paraneoplastic syndromes. Curr Opin Neurol 10: 471-476, 1997
6. Voltz RD, Posner JB, Dalman J et al.: Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumor. J Neurol Neurosurg Psychiatry 63: 133-136, 1997
7. Lang B, Vincet A: Autoimmunity to ion-channels and other proteins in paraneoplastic disorders. Curr Opin Immunol 8: 865-871, 1996
8. Graus F, Vega F, Delattre J-Y et al.: Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42: 536-540, 1992
9. Uchuga M, Graus F, Vega F et al.: Intravenous immunoglobulin treatment in paraneplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60: 388-392, 1996
10. Furneaux HM, Reich L, Posner JB: Autoantibody synthesis in the central nervous system of patients with paraneplastic syndromes. Neurology 40: 1085-1091, 1990
11. Hinton RC: Paraneoplastic neurologic syndromes. Hematol Oncol Clin North Am 10: 909-925, 1996
12. Chalk CH, Windebank AJ, Kimmel DW et al.: The distinctive clinical features of paraneoplastic sensory neuropathy. Can J Neurol Sci 19: 346-351, 1992
13. Voltz R, Gultekin SH, Rosenfeld MR et al.: A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 340: 1788-1795, 1999
14. Graus F, Cordon C, Posner JB: Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35: 538-543, 1985
15. Smeyne RJ, Vendrell M, Hayward M et al.: Continous c-fos expression precedes programmed cell death in vivo. Nature 363: 166-169, 1993
16. Anderson NE, Rosenblum MK, Posner JB: Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 24: 559-567, 1988
17. Peterson K, Rosenblum MK, Kotanides H et al.: Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 42: 1931-1937, 1992
18. Tanaka K, Tanaka M, Onodera O et al.: Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degeneration. J Neurol Sci 127: 153-158, 1994
19. Russo C, Cohn SL, Petruzzi MJ et al.: Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol 29: 284-288, 1997
20. Telander RL, Smithson WA, Groover RV: Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma. J Perdiatr Surg 24: 11-14, 1989
21. Anderson NE, Budde-Steffen C, Rosenblum MK et al.: Opsoclonus, mioclonus, ataxia, and encephalopathy in adults with cancer: a distict paraneoplastic syndrome. Medicine 67: 100-109, 1986
22. Luque A, Furneaux HM, Ferziger R et al.: Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 29: 241-251, 1991
23. Jacobson DM, Thirkill CE, Tipping SJ: A clinical trial to diagnose paraneoplastic retinopathy. Ann Neurol 28: 162-167, 1990
24. Grunwald GB, Klein R, Simmonds MA et al.: Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet 1: 658-661, 1985
25. Stayer C, Meinck HM: Stiff-man syndrome: an overview. Neurologia 13: 83-88, 1998
26. Helfgott SM: Stiff-man syndrome: from the bedside to the bench. Arthritis Rheum 42: 1312-1320, 1999
27. Silvestris N, Chetta G, Lucarelli A et al.: Mucocutaneous paraneoplastic syndromes (MCPS): a clinical-pathologic review. J Exp Clin Cancer Research. 17: 453-464, 1998
28. Silvestris N, Lucarelli A, Berardi T: Importance of paraneoplastic papulosquamous disorders in patients with solid tumors. J Chemotherapy 11: 237-238, 1999
29. Silvestris N, Caputi A, Chetta G et al.: Vasculiti paraneoplastiche: caratteristiche biologiche e cliniche. Eur J Oncol 4: 39-42, 1999
30. Darnell RB: The importance of defining the paraneoplastic neurologic disorders. N Engl J Med 340: 1831-1833, 1999